Zhejiang Tianyu Pharmaceutical Co Ltd (300702) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.063x

Based on the latest financial reports, Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.18 Million ≈ $34.12 Million USD) by net assets (CN¥3.72 Billion ≈ $544.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Zhejiang Tianyu Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Zhejiang Tianyu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Zhejiang Tianyu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Zhejiang Tianyu Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Tianyu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Tianyu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jadard Technology Inc. A SHG:688252	N/A
Wonik Holdings Co. Ltd KQ:030530	0.029x
Eyepoint Pharmaceuticals Inc NASDAQ:EYPT	-0.297x
Idorsia Ltd SW:IDIA	0.023x
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS IS:ECILC	0.014x
Garcia Reguera S.A. BA:REGE	-0.126x
Beijing Jiuzhou Yi Gui Environmental Technology Co. Ltd. SHG:688485	N/A
Piedmont Office Realty Trust Inc NYSE:PDM	0.040x

Annual Cash Flow Conversion Efficiency for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Tianyu Pharmaceutical Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.50 Billion ≈ $511.83 Million	CN¥344.64 Million ≈ $50.43 Million	0.099x	+882.72%
2023-12-31	CN¥3.49 Billion ≈ $510.37 Million	CN¥-43.90 Million ≈ $-6.42 Million	-0.013x	+9.66%
2022-12-31	CN¥3.50 Billion ≈ $511.43 Million	CN¥-48.70 Million ≈ $-7.13 Million	-0.014x	+80.29%
2021-12-31	CN¥3.71 Billion ≈ $542.77 Million	CN¥-262.23 Million ≈ $-38.37 Million	-0.071x	-140.30%
2020-12-31	CN¥3.55 Billion ≈ $519.00 Million	CN¥622.18 Million ≈ $91.04 Million	0.175x	-16.47%
2019-12-31	CN¥2.04 Billion ≈ $298.10 Million	CN¥427.84 Million ≈ $62.61 Million	0.210x	+286.63%
2018-12-31	CN¥1.45 Billion ≈ $211.66 Million	CN¥78.57 Million ≈ $11.50 Million	0.054x	-20.98%
2017-12-31	CN¥1.29 Billion ≈ $188.43 Million	CN¥88.52 Million ≈ $12.95 Million	0.069x	-74.66%
2016-12-31	CN¥607.31 Million ≈ $88.87 Million	CN¥164.74 Million ≈ $24.11 Million	0.271x	+811.67%
2015-12-31	CN¥495.77 Million ≈ $72.55 Million	CN¥14.75 Million ≈ $2.16 Million	0.030x	-83.12%
2014-12-31	CN¥456.22 Million ≈ $66.76 Million	CN¥80.44 Million ≈ $11.77 Million	0.176x	+101.33%
2013-12-31	CN¥453.68 Million ≈ $66.39 Million	CN¥39.73 Million ≈ $5.81 Million	0.088x	--

About Zhejiang Tianyu Pharmaceutical Co Ltd

SHE:300702 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.02 Billion CNY

Market Cap Rank

#8686 Global

#2053 in China

Share Price

CN¥20.18

Change (1 day)

+1.66%

52-Week Range

CN¥18.09 - CN¥29.77

All Time High

CN¥69.67